Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006315 · ClinicalTrials.gov registry record
Mobile Health Device Study for Myeloma Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT03006315: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03006315 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03006315 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Enrolled participants health status will be tracked by using a mobile health-monitoring device while undergoing chemotherapy for multiple myeloma.
Interventions
- DEVICE Garmin Vivofit device
- BEHAVIORAL Mobile Health quality of life assessements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-12 |
| Est. Completion | 2024-11-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03006315
The ClinicalTrials.gov registry entry for NCT03006315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Garmin Vivofit device is the first listed.
NCT03006315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03006315 about?
NCT03006315 is a clinical study titled "Mobile Health Device Study for Myeloma Patients". Enrolled participants health status will be tracked by using a mobile health-monitoring device while undergoing chemotherapy for multiple myeloma.
What is the current status of trial NCT03006315?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-12. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT03006315?
The interventions under investigation include: Garmin Vivofit device (DEVICE), Mobile Health quality of life assessements (BEHAVIORAL).
Who is sponsoring clinical trial NCT03006315?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.